1. Home
  2. CFLT vs LEGN Comparison

CFLT vs LEGN Comparison

Compare CFLT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$29.96

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.58

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
LEGN
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
5.9B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CFLT
LEGN
Price
$29.96
$22.58
Analyst Decision
Buy
Strong Buy
Analyst Count
32
13
Target Price
$29.93
$69.58
AVG Volume (30 Days)
19.6M
2.6M
Earning Date
02-10-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,113,149,000.00
$909,045,000.00
Revenue This Year
$22.76
$68.83
Revenue Next Year
$16.57
$51.27
P/E Ratio
N/A
N/A
Revenue Growth
21.57
74.75
52 Week Low
$15.64
$21.19
52 Week High
$37.90
$45.30

Technical Indicators

Market Signals
Indicator
CFLT
LEGN
Relative Strength Index (RSI) 77.11 30.88
Support Level $29.95 $21.19
Resistance Level $30.07 $28.97
Average True Range (ATR) 0.27 1.23
MACD 0.23 -0.13
Stochastic Oscillator 96.54 16.97

Price Performance

Historical Comparison
CFLT
LEGN

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: